178 related articles for article (PubMed ID: 24688598)
1. Expression of the metastasis suppressor BRMS1 in uveal melanoma.
Ventura BV; Quezada C; Maloney SC; Fernandes BF; Antecka E; Martins C; Bakalian S; di Cesare S; Burnier MN
Ecancermedicalscience; 2014; 8():410. PubMed ID: 24688598
[TBL] [Abstract][Full Text] [Related]
2. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
[TBL] [Abstract][Full Text] [Related]
3. Expression of nm23-H1 in uveal melanoma.
Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
5. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
Zhang S; Lin QD; DI W
Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
[TBL] [Abstract][Full Text] [Related]
6. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1.
Shevde LA; Samant RS; Goldberg SF; Sikaneta T; Alessandrini A; Donahue HJ; Mauger DT; Welch DR
Exp Cell Res; 2002 Feb; 273(2):229-39. PubMed ID: 11822878
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.
Slipicevic A; Holm R; Emilsen E; Ree Rosnes AK; Welch DR; Mælandsmo GM; Flørenes VA
BMC Cancer; 2012 Feb; 12():73. PubMed ID: 22356677
[TBL] [Abstract][Full Text] [Related]
8. PRDX3 is associated with metastasis and poor survival in uveal melanoma.
Ramasamy P; Larkin AM; Linge A; Tiernan D; McAree F; Horgan N; Moriarty P; Beatty S; Murphy CC; Clynes M; Kennedy S; Meleady P
J Clin Pathol; 2020 Jul; 73(7):408-412. PubMed ID: 31771972
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.
Li J; Cheng Y; Tai D; Martinka M; Welch DR; Li G
Oncogene; 2011 Feb; 30(8):896-906. PubMed ID: 20935672
[TBL] [Abstract][Full Text] [Related]
10. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
Zhang Y; Ye L; Tan Y; Sun P; Ji K; Jiang WG
Anticancer Res; 2014 Mar; 34(3):1417-26. PubMed ID: 24596389
[TBL] [Abstract][Full Text] [Related]
11. [DNA methylation modification of BRMS1 in triple-negative breast cancer and its correlation with tumor metastasis].
Xia J; Lü ZD; Zhou PH; Cui SC; Kong B; Liu D; Long SS; Zhang XH; Zhao JJ
Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(44):3483-3487. PubMed ID: 29275584
[No Abstract] [Full Text] [Related]
12. Fascin expression is inversely correlated with breast cancer metastasis suppressor 1 and predicts a worse survival outcome in node-negative breast cancer patients.
Lee HJ; An HJ; Kim TH; Kim G; Kang H; Heo JH; Kwon AY; Kim S
J Cancer; 2017; 8(16):3122-3129. PubMed ID: 29158783
[No Abstract] [Full Text] [Related]
13. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
14. Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival.
Cui RX; Liu N; He QM; Li WF; Huang BJ; Sun Y; Tang LL; Chen M; Jiang N; Chen L; Yun JP; Zeng J; Guo Y; Wang HY; Ma J
BMC Cancer; 2012 Aug; 12():376. PubMed ID: 22931099
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
16. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
[TBL] [Abstract][Full Text] [Related]
17. BAP1 Immunoreactivity Correlates with Gene Expression Class in Uveal Melanoma.
See TR; Stålhammar G; Phillips S; Grossniklaus HE
Ocul Oncol Pathol; 2020 Mar; 6(2):129-137. PubMed ID: 32258021
[TBL] [Abstract][Full Text] [Related]
18. Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.
Metge BJ; Liu S; Riker AI; Fodstad O; Samant RS; Shevde LA
Oncology; 2010; 78(1):75-86. PubMed ID: 20215788
[TBL] [Abstract][Full Text] [Related]
19. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
20. Expression of EpCAM in uveal melanoma.
Odashiro DN; Odashiro AN; Pereira PR; Godeiro K; Antecka E; Di Cesare S; Burnier MN
Cancer Cell Int; 2006 Nov; 6():26. PubMed ID: 17125516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
